IDO-1 activity can lead to the inhibition of T-cells by suppression of effector T-cell function and activation of regulatory T-cells [8,9], which is a potential mechanism enabling tumor cells to avoid host immune response. This evidence concerns the gene IDO1 and neoplasm.